Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

NCT00002554 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: busulfan
DRUG: cyclophosphamide
DRUG: methotrexate
PROCEDURE: allogeneic bone marrow transplantation
RADIATION: radioimmunotherapy

Sponsor

Fred Hutchinson Cancer Center